White Papers
-
Beyond The Benchmark: Innovative Trial Designs Transform Research
1/15/2026
Adaptive designs, decentralized models, and AI insights are reshaping trials — boosting efficiency, speeding timelines, and strengthening evidence amid evolving regulations and funding pressures.
-
Empower Your Trial With Data And Evidence
1/14/2026
Fuel your clinical development and decision-making with insights from fit-for-purpose data and evidence.
-
A New, AI-Augmented Horizon For Safety And Pharmacovigilance
1/6/2026
Is your organization leveraging AI to maximize efficiency in safety and regulatory workflows? If not, explore how these technologies are slated to improve industry approaches in 2026.
-
AI-Driven Signal Management: The Future Of Drug Safety
12/19/2025
By combining autonomy with robust governance, agentic AI enables pharmacovigilance teams to move from reactive to proactive safety management, anticipating risks before they materialize.
-
Addressing Trial Design Hurdles Across Alzheimer’s Disease Stages
12/10/2025
Explore how endpoint selection, rater training, and the strategic implementation of eCOA can help address the unique scientific, operational, and human considerations at each stage of AD.
-
Digital Endpoint Resource Guide: Sleep Disorders
12/10/2025
Sensor-driven digital endpoints track sleep patterns and disruptions, standardize trial outcomes, and enable remote monitoring that reduces patient burden while improving treatment-response insights.
-
Clinical Trial Starts Rose At Slower Pace In 2024
12/8/2025
Clinical trial starts grew 5.5% to 10,503 in 2024, a slowdown from 2023’s 9.4% rise in trial starts. Sustained geopolitical and global regulatory pressures on pharma contributed to curbing momentum.
-
Human-Centered RTSM Design Enhances Data, Safety, And Operations
12/5/2025
Uncover how this human-centered approach to RTSM prioritizes user experience (UX) and interface design (UI) to reduce complexity, minimize errors, and improve compliance.
-
Endpoint Clinical RTSM: Getting The Job Done
12/5/2025
Explore how a Job-to-be-Done (JTBD)-focused RTSM approach reduces delays, optimizes costs, and accelerates trial success through predictive intelligence and streamlined global workflows.
-
The Real Cost In CNS Trials: Rater Drift And Site Readiness
11/21/2025
Learn how to build resilience into CNS trial operations with evidence-based frameworks that prioritize human factors alongside digital tools.